ConductScience.org, home

Trial · NCT07881718

Injection Target in Sacroiliac Joint Dysfunction

NCT07881718, Completed, Fatih Sultan Mehmet Training and Research Hospital

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Injection Target in Sacroiliac Joint Dysfunction. Trials, record NCT07881718. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07881718

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Injection Target in Sacroiliac Joint Dysfunction
NCT number
NCT07881718
Status
Completed
Enrollment
30 participants, actual
Lead sponsor
Fatih Sultan Mehmet Training and Research Hospital
Conditions
Sacroiliac Joint Dysfunction, Multifidus, Pain Management
Interventions
Ultrasound-Guided Sacroiliac Joint Injection, Ultrasound-Guided Multifidus Injection
First posted
2026-10-19
Last updated
2026-11-12

Source ClinicalTrials.gov

Registered outcomes1

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryChange in pain intensity during movement (Visual Analog Scale, VAS)Baseline and 30 minutes after injection
Pain intensity during movement was assessed using a 0-10 cm visual analog scale (0 = no pain, 10 = worst imaginable pain). Higher scores indicate greater pain intensity and therefore a worse outcome. The outcome measure is the change from baseline to 30 minutes after injection.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07881718

GET https://conductscience.org/api/trials/v1/NCT07881718/registered